首页 | 官方网站   微博 | 高级检索  
     


Efficacy and safety of TNF blockers and of ustekinumab in palmoplantar pustulosis and in acrodermatitis continua of Hallopeau
Authors:B Husson  C Barbe  S Hegazy  J Seneschal  F Aubin  E Mahé  D Jullien  E Sbidian  M D'Incan  C Conrad  E Brenaut  C Girard  MA Richard  H Bachelez  M Viguier  For the « Groupe de Recherche sur le Psoriasis » de la Société Française de Dermatologie
Affiliation:1. Dermatology Department, Hôpital Robert-Debré, Reims, France;2. Clinical Research Unit, Hôpital Robert-Debré, Reims, France;3. Dermatology Department, Hôpital Larrey, Toulouse, France;4. Dermatology Department, National Reference Center for Rare Skin Diseases, Hôpital Saint-André, Bordeaux, France;5. Dermatology Department, Centre Hospitalo-Universitaire (CHU), Besançon, France;6. Dermatology Department, Centre Hospitalier (CH), Argenteuil, France;7. Clinical Immunology Department, CH Lyon-Sud, Lyon, France;8. Dermatology Department, Hôpital Henri-Mondor, Créteil, France;9. Dermatology Department, CHU Estaing, Clermont-Ferrand, France;10. Dermatology Department, Lausanne University Hospital, CHUV, Lausanne, Switzerland;11. Dermatology Department, CHU, Brest, France;12. Dermatology Department, CHU Lapeyronie, Montpellier, France;13. Dermatology Department, CEReSS-EA 3279, Research Center in Health Services and Quality of Life Aix Marseille University, Universitary Hospital Timone, Assistance Publique Hôpitaux de Marseille, Marseille, France;14. Université de Paris, Paris, France

Dermatology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France

Laboratory of Genetics of Skin Diseases, INSERM UMR1163, Institut Imagine, Necker Hospital, Paris, France

Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号